New Treatment for Melanoma Gets FDA Approval

WEDNESDAY, Oct. 28, 2015 — A genetically engineered cold sore virus that “blows up” melanoma tumors has been approved by the U.S. Food and Drug Administration to help treat the deadly skin cancer.
Imlygic (talimogene laherparepvec), a…
Source: Topamax